From conception to development to commercialisation, our growth is aided by cost-effective drug development and substantial manufacturing. Bright Future provides a stable supply of high-quality and reliable products. With four main manufacturing sites located in Hong Kong, Haikou, Los Angeles and Hamburg, Bright Future has manufacturing capabilities for stable production of both drugs and health products across our value chain. We market and distribute our products in over 12 countries. We are also engaged in contract manufacturing with state-of-the-art equipment, whereby we undertake selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical and healthcare products.
State-of-the-art manufacturing capabilities
We have four state-of-the-art formulation manufacturing facilities located in Hong Kong, Haikou, Los Angeles and Hamburg. Our facilities have received accreditations from the following regulatory bodies: